Related content

Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome

By  

Current Pharmacogenomics, Vol. 1, Iss. 3, 2003-09 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite

Aurora kinase inhibitors in preclinical and clinical testing

By Cheung Chun Hei Antonio   Coumar Mohane Selvaraj   Hsieh Hsing-Pang   Chang Jang-Yang  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 379-398

Informa Healthcare

Access to resources Recommend Favorite

Identification and Functional Characterization of JWA Polymorphisms and their Association with Risk of Gastric Cancer and Esophageal Squamous Cell Carcinoma in a Chinese Population

By Tang Wei-Yan   Wang Lina   Li Chunping   Hu Zhi-Bin   Chen Rui   Zhu Yu-Jie   Shen Hong-Bing   Wei Qing-Yi   Zhou Jian-Wei  

Journal of Toxicology and Environmental Health, Vol. 70, Iss. 11, 2007-01 ,pp. : 885-894

Taylor & Francis Ltd

Access to resources Recommend Favorite

Aurora-B Kinase Inhibitors for Cancer Chemotherapy

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 14, 2008-12 ,pp. : 1514-1525

Bentham Science Publishers

Access to resources Recommend Favorite

CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer

By Metzger Ralf   Heukamp Lukas   Drebber Uta   Bollschweiler Elfriede   Zander Thomas   Hoelscher Arnulf H   Warnecke-Eberz Ute  

Pharmacogenomics, Vol. 11, Iss. 8, 2010-08 ,pp. : 1105-1113

Future Medicine

Access to resources Recommend Favorite